NMIH's fourth-quarter results reflect higher premiums and net investment income but lower persistency.
NMI Holdings, Inc. (NASDAQ:NMIH ) Q4 2024 Earnings Conference Call February 6, 2025 5:00 PM ET Company Participants John Swenson - Vice President of Investor Relations, and Treasury Brad Shuster - Executive Chairman Adam Pollitzer - President and Chief Executive Officer Aurora Swithenbank - Chief Financial Officer Conference Call Participants Doug Harter - UBS Terry Ma - Barclays Capital Bose George - KBW Rick Shane - J.P. Morgan Mark Hughes - Truist Securities Mihir Bhatia - Bank of America Operator Good day, and welcome to the NMI Holdings, Inc. Fourth Quarter 2024 Earnings Conference Call.
The headline numbers for NMI Holdings (NMIH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
NMI Holdings (NMIH) came out with quarterly earnings of $1.07 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.01 per share a year ago.
EMERYVILLE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its fourth quarter and full year ended December 31, 2024 after the market close on Thursday, February 6, 2025.
NMIH stock is poised to gain from higher new insurance written volume, a comprehensive reinsurance program, financial flexibility and prudent capital deployment.
The 'Undercovered' Dozen series highlights lesser-covered stocks, providing investment ideas and encouraging discussions on their potential. Arcus Biosciences is seen as a "Strong Buy" due to its promising oncology combo therapies and partnerships with Gilead and AstraZeneca. Edmund Ingham sees Sarepta Therapeutics, despite past valuation concerns, as a "Buy" with potential for >50% gain by YE25, driven by Elevidys and ongoing clinical programs.
I recommend National Mortgage Insurance over fintech Upstart due to stark valuation disparities reminiscent of past market bubbles. National Mortgage boasts a 13% earnings yield and a P/E ratio of 7.8, significantly undervalued compared to the S&P 500 and Upstart. The company's strong credit protections and low risk of mortgage defaults make it a safer investment.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors who already own the NMIH stock should retain it and new investors should wait for some more.